Linked from

The 16 pages that link to Buprenorphine, each with the reason it gives.

• NaloxoneCompared with: Unlike naloxone, buprenorphine activates opioid receptors while limiting their response.

• Opioid use disorderBroader topic: It can reduce withdrawal and craving while limiting some effects of full agonists.

• Opioid receptorRelated: Its partial agonism illustrates how receptor efficacy shapes treatment and overdose risk.

• FentanylCompared with: Unlike fentanyl, buprenorphine’s partial agonism gives it a distinct role in treatment and overdose risk.

• CodeineCompared with: Its receptor activity and clinical role differ from codeine’s full opioid agonist effects.

• Opioid analgesicsBroader topic: Its distinct receptor activity gives it a role in selected pain and addiction-treatment plans.

• MethadoneCompared with: It is a major alternative medication with a different receptor profile and prescribing pathway.

• Opioid withdrawalRelated: It can relieve withdrawal and support treatment when started at an appropriate time.

• HeroinRelated: It can reduce withdrawal and cravings in people with heroin dependence.

• Opioid epidemicBroader topic: It treats opioid use disorder with lower overdose risk than full opioid agonists.

• NaltrexoneCompared with: Buprenorphine reduces withdrawal and craving by activating receptors rather than blocking them.

• OxycodoneCompared with: Its partial agonism and use in addiction treatment contrast with oxycodone’s full agonism.

• Medication-assisted treatmentBroader topic: Its partial agonist action can relieve withdrawal and craving while limiting opioid effects.

• HydrocodoneCompared with: Its partial agonism and role in treating opioid dependence distinguish it from hydrocodone.

• ThebaineBroader topic: Its production can begin with thebaine-derived intermediates.

• IbogaineCompared with: It provides a well-studied, regulated alternative to ibogaine for opioid dependence.